A small dose of HIV? HIV vaccine mental models and risk communication

Health Education and Behavior

Volumn 36, Issue 2, 2009, Pages 321-333

  Newman, Peter A ^a   Seiden, Danielle S ^b   Roberts, Kathleen J ^c   Kakinami, Lisa ^d   Naihua Duan, ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF ROCHESTER   (United States)

Author keywords

HIV vaccines; HIV AIDS; Mental models; Qualitative research; Risk behaviors; Risk communication

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LIVE VACCINE;

ADOLESCENT; ADULT; ARTICLE; ATTITUDE TO HEALTH; FEMALE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERPERSONAL COMMUNICATION; MALE; MIDDLE AGED; POVERTY; PSYCHOLOGICAL ASPECT; RACE; RISK FACTOR; STATISTICS; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; AIDS VACCINES; COMMUNICATION; CONTINENTAL POPULATION GROUPS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MIDDLE AGED; POVERTY; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; VACCINES, ATTENUATED; YOUNG ADULT;

EID: 63849154128     PISSN: 10901981     EISSN: 15526127     Source Type: Journal    
DOI: 10.1177/1090198107305078     Document Type: Article

References (38)

1. Allen, M.A., Liang, T.S., La Salvia, T., Tjugum, B., Gulakowski, R.J., & Murgua, M. (2005). Assessing the attitudes, knowledge, and awareness of HIV vaccine research among adults in the United States. Journal of Acquired Immune Deficiency Syndromes, 40 (5). 617-624.
2. Berg, G.D., Thomas, E., Silverstein, S., Neel, C.L., & Mireles, M. (2004). Reducing medical service utilization by encouraging vaccines: Randomized controlled trial. American Journal of Preventive Medicine, 27 (4). 284-288.
3. Blower, S.M., and McLean, A.R. (1994). Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco. Science, 265, 1451-1454.
4. Cdc-Who-Unaids. (2003). Public health considerations for the use of a first generation HIV vaccine. AIDS, 17 (15). W1 - W10.
5. Charmaz, K.C. (2006). Constructing grounded theory: A practical guide through qualitative analysis. London: Sage.
6. Chitsike, I., & van Furth, R. (1999). Paralytic poliomyelitis associated with live oral poliomyelitis vaccine in child with HIV infection in Zimbabwe: Case report. British Medical Journal, 318 (7187). 841-843.
7. Danovaro-Holliday, M.C., Wood, A.L., & LeBaron, C.W. (2002). Rotavirus vaccine and the news media, 1987-2001. Journal of the American Medical Association, 287 (11). 1455-1462.
8. Dufour, A., Remis, R.S., Alary, M., Otis, J., Masse, B., Turmel, B., et al. (1999). Factors associated with hepatitis B vaccination among men having sexual relations with men in Montreal, Quebec, Canada (Omega Study Group). Sexually Transmitted Diseases, 26 (6). 317-324.
9. Esparza, J. (2005). The global HIV vaccine enterprise. International Microbiology, 8 (2). 93-101.
10. Esparza, J., Chang, M.L., Widdus, R., Madrid, Y., Walker, N., & Ghys, P.D. (2003). Estimation of "needs" and "probable uptake" for HIV/AIDS preventive vaccines based on possible policies and likely acceptance (WHO/UNAIDS/IAVI study). Vaccine, 21 (17 / 18). 2032-2041.
11. Fischhoff, B., Bostrom, A., & Quadrel, M.J. (1993). Risk perception and communication. Annual Review of Public Health, 14, 183-203.
12. Frankel, M.R., Shapiro, M.F., Duan, N., Morton, S.C., Berry, S.H., Brown, J.A., et al. (1999). National probability samples in studies of low-prevalence diseases. Part II: Designing and implementing the HIV cost and services utilization study sample. Health Services Research, 34, 969-992.
13. Ganguly, R., & Webster, T.B. (1995). Influenza vaccination in the elderly. Journal of Investigational Allergology & Clinical Immunology, 5 (2). 73-77.
14. Girard, M.P., Osmanov, S.K., & Kieny, M.P. (2006). A review of vaccine research and development: The human immunodeficiency virus (HIV). Vaccine, 24, 4062-4081.
15. Guinan, M.E. (1993). Black communities' belief in "AIDS genocide." A barrier to overcome for HIV prevention. Annals of Epidemiology, 3 (2). 193-195.
16. Haber, P., DeStefano, F., Angulo, F.J., Iskander, J., Shadomy, S.V., Weintraub, E., et al. (2004). Guillain-Barre syndrome following influenza vaccination. Journal of the American Medical Association, 292 (20). 2478-2481.
17. Herek, G.M., Capitanio, J.P., & Widaman, K.F. (2002). HIV-related stigma and knowledge in the United States: Prevalence and trends, 1991-1999. American Journal of Public Health, 92 (3). 371-377.
18. Hershey, J., Asch, D.A., Thumasathit, T., & Meszaros, J. (1994). The roles of altruism, free riding, and bandwagoning in vaccination decisions. Organizational Behavior and Human Decision Processes, 59, 177-187.
19. Hu, D.J., Vitek, C.R., Bartholow, B., & Mastro, T.D. (2003). Key issues for a potential human immunodeficiency virus vaccine. Clinical Infectious Diseases, 36 (5). 638-644.
20. Institute of Medicine. (2000). Calling the shots: Immunization finance policies and practices. Washington, DC: National Academies Press.
21. International AIDS Vaccine Initiative. (2006). Ongoing trials of preventative HIV vaccines, updated: June 2006. Retrieved February 16, 2007, from http://www.iavireport.org/specials/OngoingTrialsofPreventiveHIVVaccines.pdf
22. Lincoln, Y., & Guba, E.G. (1985). Naturalistic inquiry. Newbury Park, CA: Sage.
23. MacIntyre, C.R., & Leask, J. (2003). Immunization myths and realities: Responding to arguments against immunization. Journal of Paediatrics and Child Health, 39 (7). 487-491.
24. McKnight, A., & Clapham, P.R. (1995). Immune escape and tropism of HIV. Trends in Microbiology, 3 (9). 356-361.
25. Morgan, D. (1998). The focus group guidebook. Thousand Oaks, CA: Sage.
26. Morgan, M.G., Fischhoff, B., Bostrom, A., Lave, L., & Atman, C.J. (1992). Communicating risk to the public: First, learn what people know and believe. Environmental Science and Technology, 26 (11). 2048-2056.
27. National Institutes of Health. (2003). Many Americans think an AIDS vaccine already exists. Retrieved November 3, 2005, from http://www.nih.gov/ news/pr/may2003/niaid-15.htm.
28. Neighbors, K., Oraka, C., Shih, L., & Lurie, P. (1999). Awareness and utilization of the hepatitis B vaccine among young men in the Ann Arbor area who have sex with men. Journal of American College Health, 47 (4). 173-178.
29. Newman, P.A., Duan, N., Rudy, E.T., & Anton, P.A. (2004). Challenges for HIV vaccine dissemination and clinical trial recruitment: If we build it, will they come ? AIDS Patient Care and STDS, 18 (12). 691-701.
30. Newman, P.A., Duan, N., Rudy, E.T., & Johnston-Roberts, K. (2004). HIV risk and prevention in a post vaccine context. Vaccine, 22 (15 / 16). 1954-1963.
31. Newman, P.A., Duan, N., Rudy, E.T., Roberts, K.J., & Swendeman, D. (2004). Posttrial HIV vaccine adoption: Concerns, motivators, and intentions among persons at risk for HIV. Journal of Acquired Immune Deficiency Syndromes, 37 (3). 1393-1403.
32. Newman, P.A., Duan, N., Lee, S.-J., Rudy, E.T., Seiden, D.S., Kakinami, L., & Cunningham, W.E. (2006). HIV vaccine acceptability among communities at risk: The impact of vaccine characteristics. Vaccine, 24, 2094-2101.
33. Pickle, K., Quinn, S.C., & Brown, J.D. (2002). HIV/AIDS coverage in Black newspapers, 1991-1996: Implications for health communication and health education. Journal of Health Communication, 7 (5). 427-444.
34. Roberts, K.J., Newman, P.A., Duan, N., & Rudy, E. (2005). HIV vaccine knowledge and beliefs among communities at elevated risk: Conspiracies, questions, and confusion. Journal of the National Medical Association, 97 (12). 1662-1671.
35. Ryan, J., Zoellner, Y., Gradl, B., Palache, B., & Medema, J. (2006). Establishing the health and economic impact of influenza vaccination within the European Union 25 countries. Vaccine, 24, 6812-6822.
36. Walter, F.M., & Britten, N. (2002). Patients' understanding of risk: A qualitative study of decision-making about the menopause and hormone replacement therapy in general practice. Family Practice, 19 (6). 579-586.
37. World Health Organization. (2007). Influenza. In Immunization, vaccines, and biologicals. Retrieved February 9, 2007, from http://www.who.int/ immunization/topics/influenza/en/index.html
38. Zimmerman, R.K., & Ball, J.A. (1998). Vaccinations in adults: Missed opportunities. American Family Physician, 58 (4). 850, 853-854.